Select Page

An Asian specialty healthcare company needed to assess the US market potential for two novel image guidance medical device systems for minimally invasive cardiac interventions.

Navigating the complex nuances of image guidance systems—particularly in the settings of percutaneous coronary intervention (or angioplasty with stent) and atrial fibrillation ablation procedures—Shift Health designed a consultation guide and interviewed key opinion leaders to understand unmet medical needs, test specific elements of the products’ clinical value propositions and uncover operational and commercial drivers of market uptake. We evaluated risks associated with each product and generated an incisive report.

The client used evidence-based insights from Shift Health’s report to support its due diligence efforts, which resulted in a $7.5M investment in the company.